Koers Oramed Pharmaceuticals, Inc. OTC Bulletin Board
Aandelen
US68403P1049
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Omzet 2024 * | 750K 701K | Omzet 2025 * | 2 mln. 1,87 mln. | Marktkapitalisatie | 91,42 mln. 85,41 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 | Nettowinst (verlies) 2025 * | -14 mln. -13,08 mln. | EV/omzet 2024 * | 122 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 45,7 x |
K/w-verhouding 2024 * |
-225
x | K/w-verhouding 2025 * |
-6,82
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 12-04-02 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12-04-02 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 14-04-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12-04-02 |
Miriam Kidron
FOU | Founder | 83 | 12-04-02 |
Leonard Sank
BRD | Director/Board Member | 59 | 23-10-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
+35,79% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |
- Beurs
- Aandelen
- Koers ORMP
- Koers